≥15% hydroxyanthracene heterosides calculated as glucofrangulin A

≥27.0% ≤33.0% of of proanthocyanidins by spectrophotometry (DMAC method)

≥6% as alpha amylase inhibitor by HPLC
1.100 U/mg of alpha amylase inhibiting activity
≥ 10.000 ≤ 30.000 HAU/g of hemagglutinating activity by
spectroph./enzym.

≥0.3% flavonoids expressed as luteolin-7-O-glucoside, ≥2.5% caffeoylquinic acid expressed as chlorogenic acid, ≥0.6% chlorogenic acid by HPLC

≥5% of total triterpenic glycosides

≥0.05% of boldin by TLC ≤0.2% of total alkaloids by acidometry

≥9.0% ≤11.0% of saponins calculated as ruscogenins by spectrophotometry

≥19% ≤21% hydroxyanthracene derivatives expressed as barbaloin

≥20.0% ≤25.0% of cascarosides expressed as cascaroside A by spectrophotometry

≥25% boswellic acids by HPLC

≥30.0% ≤35.0% of selected triterpenes by HPLC

≥45.0% of the sum of asiaticoside, madecassoside, asiatic and madecassic acids by HPLC

≥1.2% of total apigenin by HPLC

≥1.0% of anthraquinones as aloe-emodin by spectrophotometry

≥13.0 ≤18.0% of caffeoylquinic acids by HPLC

≥85.0% of fatty acids by GC

≥18.0% ≤22.0% of curcuminoids by HPLC

≥1.8% ≤2.2% of harpagoside by HPLC

≥1.8% ≤2.2% of harpagoside by HPLC

≥0.8% of caftaric, chicoric, chlorogenic acids and echinacoside by HPLC

≥0.5% of eleutheroside E by HPLC

≥95.0% of proanthocyanidins by spectrophotometry,
≥5.0% ≤15.0% of catechin and epicatechin by HPLC

≥30.0% of total ginkgoterpenes, ≥10.0% of bilobalide, ≥10.0% of ginkgolides A, B, C, J by HPLC

≥24% of ginkgoflavoglucosides by HPLC
≥6% as sum of ginkgolides A, B,C and bilobalide by HPLC
≤5 ppm of total ginkgolic acids by HPLC

≥24% of ginkgoflavonglucosides by HPLC
≤0.1% of sum of ginkgolides A, B, C and bilobalide